MX vs NVDA

Magnachip (MX) exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 0/9, indicating a total lack of improvement in financial health across all measured dimensions. While the company maintains a strong liquidity position with a Current Ratio of 4.07 and low debt (D/E 0.19), these are offset by a collapsing top line, with YoY revenue growth at -20.70% and Q/Q growth at -35.64%. The company is consistently unprofitable with negative operating margins of -30.68%, and the stock is trading at a significant discount to book value (P/B 0.48), suggesting the market is pricing in continued asset impairment or business model failure.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.